Pharma
Uniphar profits climb 27 per cent on the back of booming supply chain and pharma growth
The pharma company reported over 34 per cent growth in its supply chain, retail and pharma wings, with more modest growth in its medtech division
Uniphar’s operating profits grew by more than 27 per cent to €67.7 million last year, driven by strong growth in its supply chain, retail and pharma divisions.
The company’s profits jumped from €53.1 million the previous year as its strongly performing divisions delivered growth of more than 34 per cent in gross profit terms.
Ger Rabbette, chief executive, said the firm’s performance was strong this year and they made further progress on their strategic objectives.
